clinical trials

Trial sets up 2020 filing for Poxel’s novel diabetes drug
Trial sets up 2020 filing for Poxel’s novel diabetes drug
Pharmaforum
Poxel
Japan
diabetes
type 2 diabetes
clinical trials
imeglimin
Flag link:
Potential Cancer "Vaccine" Shows Promise in Early-Stage NHL Trial
Potential Cancer "Vaccine" Shows Promise in Early-Stage NHL Trial
BioSpace
vaccines
cancer vaccines
Mount Sinai
non-Hodgkin lymphoma
clinical trials
Flag link:
NanOlogy enrolls first patient in phase 1/2 clinical trial of NanoDoce to treat bladder cancer
NanOlogy enrolls first patient in phase 1/2 clinical trial of NanoDoce to treat bladder cancer
Pharmaceutical Business Review
NanOlogy
bladder cancer
NanoDoce
clinical trials
Flag link:
Probiotic Derived SkinBiotix Shows Efficacy in Increasing Skin Hydration
Probiotic Derived SkinBiotix Shows Efficacy in Increasing Skin Hydration
CP Wire
SkinBioTherapeutics
clinical trials
SkinBiotix
dermatology
Flag link:
United Therapeutics tosses out esuberaprost after trial flop
United Therapeutics tosses out esuberaprost after trial flop
Fierce Biotech
United Therapeutics
PAH
esuberaprost
clinical trials
Flag link:
Achillion Meets Enrollment Target in Kidney Disease Studies
Achillion Meets Enrollment Target in Kidney Disease Studies
Yahoo/Zacks.com
Achillion
ACH-4471
kidney disease
clinical trials
Flag link:
Sangamo Stock Soars on Positive Hemophilia Treatment Trial
Sangamo Stock Soars on Positive Hemophilia Treatment Trial
TheStreet.com
Sangamo BioSciences
Pfizer
SB-525
hemophilia
clinical trials
Flag link:
Inovio Closes Enrollment in Brain Cancer Study Before Time
Inovio Closes Enrollment in Brain Cancer Study Before Time
Yahoo/Zacks.com
Inovio
clinical trials
INO-5401
INO-9012
Libtayo
glioblastoma
Flag link:
Roche's ipatasertib-Tecentriq combo leads to 73% ORR in TNBC patients
Roche's ipatasertib-Tecentriq combo leads to 73% ORR in TNBC patients
BioCentury
Roche
clinical trials
Ipatasertib
metastatic triple-negative breast cancer
AACR
Flag link:
Supernus struggles to gain attention
Supernus struggles to gain attention
EP Vantage
Supernus
ADHD
SPN-812
clinical trials
Flag link:
Pfizer squeezes out positive data for fructose-fighting NASH drug
Pfizer squeezes out positive data for fructose-fighting NASH drug
Biopharma Dive
Pfizer
NASH
clinical trials
Flag link:
Gilead earns needed trial win as arthritis drug succeeds in 2 studies
Gilead earns needed trial win as arthritis drug succeeds in 2 studies
Biopharma Dive
Gilead Sciences
filgotinib
clinical trials
FDA
Flag link:
Little Proteon shares crash into penny stock territory as lead drug flops in PhIII
Little Proteon shares crash into penny stock territory as lead drug flops in PhIII
Endpoints
Proteon Therapeutics
chronic kidney disease
vonapanitase
clinical trials
Flag link:
Acadia to Move Experimental Pediatric Rett Syndrome Drug to Phase 3
Acadia to Move Experimental Pediatric Rett Syndrome Drug to Phase 3
Xconomy
Acadia Pharmaceuticals
pediatrics
Rett Syndrome
clinical trials
trofinetide
Flag link:
After a delay, Can-Fite digs into subpopulation data as liver cancer drug fails to hit primary endpoint
After a delay, Can-Fite digs into subpopulation data as liver cancer drug fails to hit primary endpoint
Fierce Biotech
Can-Fite BioPharma
liver cancer
namodenoson
clinical trials
Flag link:
Eyedrops Instead of Reading Glasses – Company Begins Ph IIb Trial
Eyedrops Instead of Reading Glasses – Company Begins Ph IIb Trial
CP Wire
Orasis Pharmaceuticals
clinical trials
presbyopia
Flag link:
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
Xconomy
Aldeyra Therapeutics
clinical trials
FDA
eye health
reproxalap
seasonal allergic conjunctivitis
Flag link:
Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan
Aerie (AERI) Starts Phase II Study on Eye Candidate in Japan
Yahoo/Zacks.com
Aerie Pharmaceuticals
clinical trials
Japan
Open-Angle Glaucoma
Flag link:
RIP amyloid beta theory? Nope. Biogen partner launches a new PhIII before aducanumab's corpse turned cold
RIP amyloid beta theory? Nope. Biogen partner launches a new PhIII before aducanumab's corpse turned cold
Endpoints
Biogen
Eisai
BAN2401
Alzheimer's disease
clinical trials
Flag link:
Conatus and Novartis suffer another midphase NASH flop
Conatus and Novartis suffer another midphase NASH flop
Fierce Biotech
Conatus
Novartis
NASH
emricasan
clinical trials
Flag link:

Pages